Effect of p53 gene transfer and cisplatin in a peritonitis carcinomatosa model with p53-deficient ovarian cancer cells

Gynecologic Oncology

Volumn 84, Issue 2, 2002, Pages 210-215

  Kigawa, Junzo ^a   Sato, Shinya ^a   Shimada, Muneaki ^a   Kanamori, Yasunobu ^a   Itamochi, Hiroaki ^a   Terakawa, Naoki ^a  

^a TOTTORI UNIVERSITY   (Japan)

Author keywords

Cisplatin; Ovarian cancer; p53 gene; Peritonitis carcinomatosa model

Indexed keywords

4 [5 (4 METHYL 1 PIPERAZINYL)[2,5' BI 1H BENZIMIDAZOL] 2' YL]PHENOL; BETA GALACTOSIDASE; CISPLATIN; PROTEIN P53;

ADENOCARCINOMA; APOPTOSIS; ARTICLE; CANCER CELL; CANCER PATIENT; CANCER SURVIVAL; CARCINOMATOUS PERITONITIS; GENE DELETION; GENE TRANSFER; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; REPORTER GENE;

EID: 0036173498     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.2001.6488     Document Type: Article

References (20)

1. The biology of ovarian cancer
2. Mechanisms and modulation of resistance to chemotherapy in ovarian cancer
3. Long-term follow-up of patients with advanced ovarian carcinoma treated with chemotherapy
4. p53 gene therapy in a rat model of hepatocellular carcinoma: Intra-arterial delivery of a recombinant adenovirus
5. Efficacy of p53 adenovirus-mediated gene therapy against human breast cancer xenografts
6. Cancer gene therapy using a novel adeno-associated virus vector expressing human wild-type p53
7. A newly developed adenovirus-mediated transfer of a wild-type p53 gene increases sensitivity to cis-diamminedichloroplatinum (II) in p53-deleted ovarian cancer cells
8. Alterations of the p53 gene and p53 protein expression in epithelial-ovarian cancer before and after chemotherapy
9. Association between cisplatin resistance and mutation of p53 gene and reduced bax expression in ovarian carcinoma cell systems
10. Transient immunosuppression permits successful repetitive intravenous administration of an adenovirus vector
11. In vivo studies of adenovirus-based p53 gene therapy for ovarian cancer
12. Intraperitoneal gene therapy with adenoviral-mediated p53 tumor suppressor gene for ovarian cancer model in nude mouse
13. In vivo studies of adenovirus-mediated p53 gene therapy for cis-platinum-resistant human ovarian tumor xenografts
14. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding
15. Cell kinetics and chemosensitivity of human carcinomas serially transplanted into nude mice
16. Statistical logic in the monitoring of reactions to therapeutic drugs
17. The prognostic significance of Bcl-2 and p53 expression in ovarian cancer
18. Mechanism of combination effect of wild-type p53 gene transfection and cisplatin for ovarian cancer xenografts
19. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene
20. Gene therapy for lung cancer: Enhancement of tumor suppression by a combination of sequential systemic cisplatin and adenovirus-mediated p53 gene transfer